22Health Ventures

22Health Ventures operates as an early-stage venture capital firm dedicated to advancing health technology. The firm provides strategic capital and hands-on business-building support, coupled with mentorship, to foster innovation within the healthtech ecosystem. Its approach is centered on leveraging deep entrepreneurial experience to accelerate the development and market entry of promising health solutions globally.

The firm was co-founded in 2023 by Ara Tavitian and Paul Scibetta, who observed a critical need for experienced guidance and patient capital in the burgeoning health technology sector. Their insight was to establish a unique investment model that not only funds but actively mentors nascent healthtech enterprises, drawing on their own successful entrepreneurial backgrounds to bridge the gap between innovation and market impact.

Early-stage healthtech founders constitute the core beneficiaries of 22Health Ventures' offerings. The firm's long-term vision is to empower a new generation of companies to bring transformative health solutions to fruition, ultimately aiming to shape the future of healthcare through strategic investment and partnership. The focus remains on identifying and nurturing ventures poised for significant global influence.